Pharmaceutical

Listen: How Long Island became the ‘eugenics capital of...

In a new episode of "Color Code," STAT explores the history of a Long Island lab...

STAT+: FDA warns AstraZeneca over misleading promotiona...

The FDA scolded AstraZeneca for making misleading claims about the effectiveness...

STAT+: SEC wants to know if key supplier of research mo...

The move comes as the Department of Justice probes a Cambodian smuggling ring th...

America’s ERs struggle with timely care for stroke pati...

Black, Hispanic, and female patients, as well as those over 80 all experienced l...

YouTube cracks down on misinformation on cancer treatment

YouTube’s health division is stepping up its effort to combat medical informatio...

STAT+: Pharmalittle: Amazon Pharmacy offers insulin dis...

Amazon Pharmacy will begin automatically applying manufacturer coupons to more t...

Radiation, a mainstay of cancer treatment, begins a fad...

“There are situations now on an individual patient basis where radiation may not...

STAT+: BMS, looking to build a market for a heart drug,...

As Bristol Myers Squibb works to build Camzyos into a blockbuster drug, it has p...

Patient advocates warn FDA proposal on salt intake coul...

Patient advocates are warning that a proposal from the FDA meant to reduce consu...

Opinion: Home blood pressure machines are often wrong. ...

These popular machines may be wildly inaccurate for people with wider or longer ...

House Democrats unveil new legislation that expands the...

In July, Democratic health leaders from the US House of Representatives proposed...

Botulinum battle heats up with FDA approving Daxxify fo...

Daxxify becomes the latest botulinum toxin to make the jump from aesthetics to t...

LifeArc invests nearly $10m in Crick Institute’s Africa...

The funding will extend support to the Institute’s Crick Africa Network for five...

Valneva pushes FDA approval date for chikungunya vaccine

The PDUFA date has been pushed by three months to November to allow for more tim...

Novartis acquires Chinook for $3.2bn to boost kidney di...

Novartis obtains two Phase III drugs, atrasentan and zigakibart, and Chinook is ...

How the pharma industry can benefit from using modular ...

New advancements in cold chain monitoring are poised to revolutionise the pharma...